QQ客服 官方微博 反馈留言

	Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy
	Xu, Lu; Xu, Xin-Hua; Yuan, Cheng; Zhang, Jia-Yu; Tang, Xi; Chen, Dian; Wang, Xiao-Long; Zeng, Guang
刊名	ANNALS OF TRANSLATIONAL MEDICINE
	2018
卷号	6期号:20
关键词	Nonsquamous non-small cell lung cancer (Nonsquamous NSCLC) icotinib unknown EGFR mutation survival analysis adverse effect
ISSN号	2305-5839
DOI	10.21037/atm.2018.09.54
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4140457
专题	武汉大学
推荐引用方式 GB/T 7714	Xu, Lu,Xu, Xin-Hua,Yuan, Cheng,et al. Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy[J]. ANNALS OF TRANSLATIONAL MEDICINE,2018,6(20).
APA	Xu, Lu.,Xu, Xin-Hua.,Yuan, Cheng.,Zhang, Jia-Yu.,Tang, Xi.,...&Zeng, Guang.(2018).Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy.ANNALS OF TRANSLATIONAL MEDICINE,6(20).
MLA	Xu, Lu,et al."Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy".ANNALS OF TRANSLATIONAL MEDICINE 6.20(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。